Otomycosis in Western Iran: Clinical and Mycological Aspects

Sajad Cheraghsahar; Siros Kazemi; Mehdi Birjandi; Mohammad Yarahmadi; Shahram Mahmoudi; Rasoul Mohammadi; Asghar Sepahvand

doi:10.5812/archcid.57287

Otomycosis in Western Iran: Clinical and Mycological Aspects

Sajad Cheraghsahar ¹ , Siros Kazemi ² , Mehdi Birjandi ³ , Mohammad Yarahmadi ^{4
, 5} , Shahram Mahmoudi ^{4
, 6} , Rasoul Mohammadi ⁷ and Asghar Sepahvand ^{5
, *}

Authors Information

¹ Students Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran

² Department of ENT, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

³ Department of Biostatistics, Lorestan University of Medical Sciences, Khorramabad, Iran

⁴ Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

⁵ Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

⁶ Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

⁷ Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Article information

Archives of Clinical Infectious Diseases: April 2017, 12 (2); e57287
Published Online: April 30, 2017
Article Type: Research Article
Received: August 19, 2016
Revised: January 5, 2017
Accepted: February 5, 2017
DOI: 10.5812/archcid.57287

To Cite: Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, et al. Otomycosis in Western Iran: Clinical and Mycological Aspects, Arch Clin Infect Dis. 2017 ; 12(2):e57287. doi: 10.5812/archcid.57287.

Abstract

Methods: In this cross-sectional descriptive study, a total of 79 patients clinically suspected to otomycosis were recruited from April 2014 to April 2015. Specimens were collected using sterile swabs. All the specimens were subjected to direct examination using 10% KOH, and culture in Sabouraud dextrose agar containing chloramphenicol, malt-extract agar, and Czapek Dox agar. CHROMagar candida and carbohydrate assimilation profile in API 32 C were used for the identification of yeasts.

Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Fungal involvement of the external ear, known as otomycosis, is a globally distributed superficial infection of the auricle and external auditory canal (1). Humid and warm climates, poor hygiene, application of hearing aids, bacterial otitis externa, dermatomycosis, long-term exposure to water, and trauma are some factors that facilitate the occurrence of otomycosis (2-4). Immunosuppression may lead to middle ear involvement and perforation of the tympanic membrane (5).

Patients with otomycosis usually complain of itching and even pain in the ear, otorrhea, tinnitus, impaired hearing, and aural fullness (3, 5). Although these symptoms are common, they are not pathognomonic for otomycosis (2, 6). Accordingly, clinical signs and symptoms should be approved by mycological methods including direct examination and culture.

Species from Aspergillus and Candida genera are recognized as the most frequently isolated agents of otomycosis (7, 8). Other fungi like Penicillium spp., Mucor spp., Fusarium spp., and Alternaria spp. are sporadically reported, as well (3, 7, 9).

Efficient treatment of otomycosis usually requires multiple procedures including resolving the predisposing factors, mechanical removal and cleaning of debris, and appropriate antifungal therapy (10). The route of antifungal drug administration is usually topical. Systemic therapy is necessary in immunocompromised patients as well as in cases with severe and invasive forms such as fungal mastoiditis. Topical forms of miconazole, clotrimazole, bifonazole, tolnaftate, ciclopiroxolamine, and amphotericin-B as well as triazoles such as voriconazole, itraconazole, and posaconazole for oral administration are instances of available therapies for otomycosis. Furthermore, other compounds like fuchsin, solutions of gentian violet (crystal violet), and mercurochrome may be used (7, 11). Nevertheless, recurrent otomycosis is not an unexpected situation. Therefore, treatment should be directly against the causal agent. Accordingly, the identification of causal fungi helps in the efficient treatment of otomycosis and provides a preventive measure for drug resistance in etiologic agents (7).

2. Objectives

3. Methods

3.1. Patients

During a one year period (from April 2014 to April 2015), a set of 79 patients suspected to otomycosis were enrolled in this study. All patients have at least one complaint indicative of otomycosis such as itching, otalgia, otorrhea, tinnitus, impaired hearing, and aural fullness.

Ethical approval: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the human research committee of Lorestan University of Medical Sciences (Ethics approval code: LUMS.REC.1394.44).

Informed consent: An informed consent was obtained from each patient took part in the study.

3.2. Specimen Collection

Specimens were obtained by sterile swabs from external auditory canal of all patients. All the specimens were transferred to a medical mycology laboratory for mycological investigations.

3.3. Mycological Testes

Direct microscopy using 10% KOH was performed on all the specimens seeking for fungal elements such as septate and aseptate hyphae, yeast and conidia cells, and conidia formation structures. Furthermore, all the specimens were cultured on Sabouraud dextrose agar (Merck, Germany) containing chloramphenicol, malt-extract agar (Merck, Germany), and Czapek Dox agar (Himedia, India) and incubated at 30°C for 2 weeks. The cultures were controlled daily, and all colonies were identified using morphological characteristics in slide cultures, colony colors on CHROMagar candida (CHROMagar, France), and carbohydrate assimilation profile in API 32 C (bioMerieux, France).

3.4. Statistical Analyses

The correlations between predisposing factors and otomycosis were statistically studied using chi-square, t-test or non-parametric tests according to the distribution of data in SPSS 18. P value < 0.05 was considered statistically significant.

4. Results

Among 79 patients enrolled in this study, 31 (39.2%) were male and 48 (60.8%) were female. According to the results of the mycological tests, otomycosis was confirmed in 15 out of 79 patients (19%). Fungal elements were seen in direct examination of all 15 cases and these findings were confirmed by positive cultures. The positive cases consisted of 4 (26.66%) males and 11 (73.33%) females. Itching was the most frequent clinical finding in 83.5% (66 of 79) of the study population and 100% (15 of 15) of the positive cases. The frequency of different clinical findings in the study population and positive cases of otomycosis are presented in Table 1.

Table 1. The Frequency of Different Clinical Findings Indicative of Otomycosis Among 15 Proven Cases of Otomycosis and all 79 Studied Patients

Clinical Finding	Positive Cases of Otomycosis (N=15)		Study Population (N=79)
	Frequency	Percentage	Frequency	Percentage
Ear itching	15	100	66	83.5
Aural fullness	8	53.2	47	59.5
Hearing impairment	8	53.2	46	58.2
Otalgia	7	46.6	47	59.5
Tinnitus	6	39.9	26	32.9
Otorrhea	5	33.3	46	58.2
Ear inflammation	4	26.6	18	22.8
Cotton-like debris	4	26.6	4	5.1
Waxy Debris in ear	3	19.9	10	12.7

The leading isolated fungal genus was Aspergillus, accounting for 6 out of 15 cases (39.96%). However, Candida albicans was the most frequent fungal species isolated from 5 out of 15 (33.33%) cases of otomycosis. Also, an uncommon case of otomycosis due to Alternaria spp. was diagnosed. Table 2 shows the frequency of different fungal species recovered from patients with otomycosis.

Table 2. The Frequency of Different Fungal Species Isolated from 15 Patients with Otomycosis

Fungal Species	Frequency	Percentage
Aspergillus flavus	4	26.64
Aspergillus niger	2	13.32
Candida albicans	5	33.33
Penicillium spp.	3	19.98
Alternaria spp.	1	6.66
Total	15	100

In this study, no statistically significant correlation was observed between otomycosis and factors like habitant, gender, swimming, application of hearing aids, trauma, and history of otitis externa. However, considering the mean age of positive (45.86 ± 14.33 years) and negative (36.36 ± 16.2 years) patients, a significant correlation between older age and otomycosis was confirmed (P value = 0.04).

5. Discussion

Otomycosis or fungal otitis externa is a fungal infection of the external ear, which can involve the middle ear in the cases of tympanic membrane perforation. It has a global distribution with higher frequency in tropical and sub-tropical regions (8, 12-14).

In our study the incidence of otomycosis among 79 suspected patients was 19% (15 out of 79). Bineshian et al. (8) reported a lower incidence (11.4%) of otomycosis among the suspected patients group in Semnan, Iran. However, higher incidences have been reported by other authors including 32.25% in Khouzestan Province, south-west of Iran (2), 43% in the north of Iran (1), 57% in Tehran (15), 69% in central Iran (4), and 92% in the north-west of Iran (11), among the study population with suspicion of otomycosis.

It has been well established that the incidence of otomycosis differs in various geographical regions due to the different climatic conditions (16, 17). Thus, the disagreement between the incidence of otomycosis in our and other studies in Iran could be due to the different geographical regions, as well as the different inclusion and exclusion criteria for patients defined by each research group.

The female gender was more commonly affected by otomycosis (73.33%, 11 of 15 patients) in our study which is in accordance with the results of other reports (1, 12, 15). Whereas, higher involvement of males was reported by some authors (11, 18).

Itching or pruritus was the most frequent symptom noted in 100% of the patients, which confirms the findings of Bhan et al. (18), Abdelazeem et al. (17), Kazemi et al. (11), Barati et al. (4), and Jia et al. (5).

C. albicans was the leading fungal species isolated from 33.33% of the patients, followed by Aspergillus flavus (26.64%) and Penicillium spp. (19.98%). C. albicans is a natural habitant of human body; infections due to this yeast in individuals with predisposing factors are not an unexpected issue (11). Pontes et al. (19) found C. albicans as the most common species isolated from 30% of the otomycosis cases in their study, which is in agreement whit our results. These findings dispute several previous publications that reported A. niger as the most frequent agent of otomycosis (11, 12, 15, 17, 20, 21). In spite of this, if we classify the etiologic agents as yeast and saprophytic molds, the majority (66.66%, 10 of 15) of our cases were due to the latter, which is in accordance with the findings of other publications (1, 2, 9, 14). Alternaria spp. is a dematiaceous fungi with rare reported cases of otomycosis in Iran (3). In the present study, we reported another case of fungal otitis externa due to this fungus.

The accurate diagnosis of otomycosis should be based on clinical and mycological criteria; in some cases imaging studies should be performed, as well (7). However, in many cases, diagnosis is completely based on clinical signs and symptoms, which are mainly unspecific (22-24).

According to the literature, the causal agents of otomycosis are highly divergent and their antifungal susceptibility profiles are different (3, 7). Also, drug resistance of etiological fungi and recurrent cases of otomycosis following unspecific treatment are reported (5, 25, 26). Therefore, mycological examinations in suspected cases of otomycosis and antifungal susceptibility testing prior to drug administration could be beneficial for accurate diagnosis and treatment.

Also, the results of Szigeti et al. (25, 27) indicated the low accuracy of conventional morphological methods in the identification of black Aspergillus species as the most frequent cause of otomycosis. Accordingly, the application of suitable identification methods is preferred to provide accurate epidemiological data, which requires further studies.

The present study provided the first report on otomycosis in Lorestan province, western Iran. However, due to the limited number of patients investigated, our results could not be generalized. Furthermore, the antifungal susceptibility pattern of isolates was not determined in our study, which is another disadvantage. Thus, additional studies incorporating larger study populations, antifungal susceptibility testing, and treatment follow-ups are necessary.

In conclusion, the incidence of otomycosis in this study was 19% and the most common causative agent was C. albicans. Similar conditions have not been found in other regions of Iran. This indicates the necessity for ENT specialists to be aware of the leading causal agent in each geographical region in order to prescribe antifungal drugs appropriately. Also, the high incidence of different clinical complaints from patients with and without proven otomycosis highlights the need for mycological examination in addition to clinical examinations in the diagnosis of otomycosis.

Acknowledgements

Footnotes

Authors’ Contribution: Asghar Sepahvand and Siros Kazemi designed and managed the study. Sajad Cheraghsahar. performed the experiments and collected data. Mehdi Birjandi analyzed the data. Mohammad Yarahmadi and Rasoul Mohammadi assisted in experiments. Shahram Mahmoudi wrote the manuscript.

Financial Disclosure: None declared.

Conflict of Interests: The authors declare that they have no conflict of interest.

Funding/Support: This study was financially supported by Lorestan University of Medical Sciences, Lorestan, Iran (grant number: 1986).

References

1. Nemati S, Hassanzadeh R, Khajeh Jahromi S, Delkhosh Nasrollah Abadi A. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014; 271(5): 953-7[DOI][PubMed]
2. Saki N, Rafiei A, Nikakhlagh S, Amirrajab N, Saki S. Prevalence of otomycosis in Khouzestan Province, south-west Iran. J Laryngol Otol. 2013; 127(1): 25-7[DOI][PubMed]
3. Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia. 2015; 179(5-6): 415-24[DOI][PubMed]
4. Barati B, Okhovvat SA, Goljanian A, Omrani MR. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011; 13(12): 873-6[PubMed]
5. Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012; 55(5): 404-9[DOI][PubMed]
6. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008; 51(1): 67-70[DOI][PubMed]
7. Vennewald I, Klemm E. Otomycosis: Diagnosis and treatment. Clin Dermatol. 2010; 28(2): 202-11[DOI][PubMed]
8. Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol. 2006; 1(4): 141-4
9. Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003; 112(4): 384-7[DOI][PubMed]
10. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135(5): 787-91[DOI][PubMed]
11. Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol. 2015; 8(9)[DOI][PubMed]
12. Desai KJ, Malek SS, Italia IK, Jha S, Pandya V, Shah H. Fungal spectrum in otomycosis at tertiary care hospital. Natl J Integr Res Med. 2012; 3(5)
13. Song JE, Haberkamp TJ, Patel R, Redleaf MI. Fungal otitis externa as a cause of tympanic membrane perforation: a case series. Ear Nose Throat J. 2014; 93(8): 332-6[PubMed]
14. Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol. 2015; 8(5)[DOI][PubMed]
15. Nowrozi H, Doustdar Arabi F, Ghaffarnejad Mehraban H, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014; 3(2): 29-31
16. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008; 72(4): 453-9[DOI][PubMed]
17. Abdelazeem M, Gamea A, Mubarak H, Elzawawy N. Epidemiology, causative agents, and risk factors affecting human otomycosis infections. Turk J Med Sci. 2015; 45(4): 820-6[DOI][PubMed]
18. Bhan C, Purohit K, Prasad Purohit J, Kumar V, Singh Yadav H. Clinical vs bacteriological and mycological evaluation in chronic suppurative otitis media. Int J Contemp Med Res. 2016; 3(5): 1443-7
19. Pontes ZB, Silva AD, Lima Ede O, Guerra Mde H, Oliveira NM, Carvalho Mde F, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009; 75(3): 367-70[DOI][PubMed]
20. Ibiam F, Adekwu A, Obasikene G, Ezeanolue B, Okoroafor I, Iroezindu M. Aetiological agents implicated in otitis externa-an update. PMJUMU. 2016; 5(9): 1-12
21. Ozcan M, Ozcan KM, Karaarslan A, Karaarslan F. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol. 2003; 260(1): 24-7[DOI][PubMed]
22. Arndal E, Glad H, Homoe P. Large discrepancies in otomycosis treatment in private ear, nose, and throat clinics in Denmark. Dan Med J. 2016; 63(5)[PubMed]
23. Kurnatowski P, Filipiak J. Otitis externa: the analysis of relationship between particular signs/symptoms and species and genera of identified microorganisms. Wiad Parazytol. 2008; 54(1): 37-41[PubMed]
24. Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. Ear Nose Throat J. 2008; 87(11): 622-3[PubMed]
25. Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012; 55(4): 333-8[DOI][PubMed]
26. Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007; 50(6): 447-50[DOI][PubMed]
27. Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012; 174(2): 143-7[DOI][PubMed]

Archives of Clinical Infectious Diseases

Published by: Kowsar

Otomycosis in Western Iran: Clinical and Mycological Aspects

Article information

Abstract

1. Background

2. Objectives

3. Methods

4. Results

5. Discussion

Acknowledgements

Footnotes

References

Readers' Comments

Archives of Clinical Infectious Diseases

Published by: Kowsar

Otomycosis in Western Iran: Clinical and Mycological Aspects

Article information

Abstract

1. Background

2. Objectives

3. Methods

4. Results

5. Discussion

Acknowledgements

Footnotes

References

Share on:

Readers' Comments:

Readers' Comments